Cargando…

Neurological symptoms in patients with COVID-19 as manifestation of severity and prognosis, the case of anosmia and dysgeusia

Detalles Bibliográficos
Autores principales:	Del Carpio-Orantes, Luis, García-Méndez, Sergio, Solís-Sánchez, Ishar, Arnulfo Perfecto-Arroyo, Miguel, Patricia Moreno-Aldama, Nancy, Salvador Sánchez-Díaz, Jesús
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498418/ http://dx.doi.org/10.1016/j.jns.2021.119899

Ejemplares similares

Anosmia and dysgeusia as markers of severity and prognosis in COVID-19
por: Carpio-Orantes, Luis Del, et al.
Publicado: (2023)

Incidence of stroke in a population affected by COVID-19 in Veracruz, México
por: Carpio-Orantes, Luis Del, et al.
Publicado: (2023)

1680. Guillain Barré Syndrome in Arbovirus Outbreak in Veracruz, Mexico: The Follow-up to 3 Years of the Pandemic
por: Del Carpio-Orantes, Luis, et al.
Publicado: (2019)

Potential Mechanisms for COVID-19 Induced Anosmia and Dysgeusia
por: Eshraghi, Adrien A., et al.
Publicado: (2020)

Anosmia and dysgeusia in COVID-19: A systematic review
por: Carrillo-Larco, Rodrigo M., et al.
Publicado: (2020)

Contribution of anosmia and dysgeusia for diagnostic of COVID-19 in outpatients
por: Zayet, Souheil, et al.
Publicado: (2020)

Can symptoms of anosmia and dysgeusia be diagnostic for COVID‐19?
por: Zahra, Syeda Anum, et al.
Publicado: (2020)

Pathogenesis and progression of anosmia and dysgeusia during the COVID-19 pandemic
por: Krishnakumar, Hari N., et al.
Publicado: (2022)

Stellate Ganglion Block for Anosmia and Dysgeusia Due to Long COVID
por: Chauhan, Gaurav, et al.
Publicado: (2022)

718. Asymptomatic campylobacteriosis as a risk factor for developing acute neurological syndromes in Veracruz, Mexico
por: Del Carpio-Orantes, Luis, et al.
Publicado: (2020)

Self-reported anosmia and dysgeusia as key symptoms of coronavirus disease 2019
por: Lee, Daniel J., et al.
Publicado: (2020)

Anosmia, hyposmia, and dysgeusia as indicators for positive SARS-CoV-2 infection
por: Lao, Wilson P., et al.
Publicado: (2020)

Transient Anosmia and Dysgeusia in COVID-19 Disease: A Cross Sectional Study
por: Ali, Fatema Ahmed, et al.
Publicado: (2023)

Guillain–Barré syndrome associated with vaccines in Veracruz, Mexico
por: Carpio-Orantes, Luis Del, et al.
Publicado: (2022)

Anosmia and Dysgeusia in the Absence of Other Respiratory Diseases: Should COVID-19 Infection Be Considered?
por: Lorenzo Villalba, Noel, et al.
Publicado: (2020)

The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients()
por: Singh, Chandra Veer, et al.
Publicado: (2021)

Should anosmia and dysgeusia be a concern for oral and maxillofacial surgeons during the COVID-19 pandemic?
por: Alharbi, Hamad, et al.
Publicado: (2021)

Sudden onset anosmia and dysgeusia in two patients: An early sign of SARS-CoV-2 infection
por: Alamri, Ahmad, et al.
Publicado: (2020)

The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in taste dysgeusia in COVID-19 patients
por: Singh, Chandra Veer, et al.
Publicado: (2021)

Neuropsychiatric manifestations in patients with long COVID in Mexico
por: Carpio-Orantes, Luis Del, et al.
Publicado: (2023)

Risk Factors for Persistent Anosmia and Dysgeusia in Children with SARS-CoV-2 Infection: A Retrospective Study
por: Mariani, Francesco, et al.
Publicado: (2023)

Guillain-Barré Syndrome, Before and After Zika
por: Del Carpio-Orantes, Luis, et al.
Publicado: (2019)

Letter to the editor regarding “The outcome of fluticasone nasal spray on anosmia and triamcinolone oral paste in dysgeusia in COVID-19 patients”
por: Verma, Ravneet Ravinder, et al.
Publicado: (2021)

Dysosmia and dysgeusia associated with duloxetine
por: Yoshida, Katsuyuki, et al.
Publicado: (2017)

Guillain-Barré syndrome, from the search for Zika to the discovery of asymptomatic campylobacteriosis as a risk factor for neurological syndromes in Veracruz, Mexico
por: Carpio-Orantes, Luis Del
Publicado: (2022)

Anosmia and dysgeusia in SARS-CoV-2 infection: incidence and effects on COVID-19 severity and mortality, and the possible pathobiology mechanisms - a systematic review and meta-analysis
por: Mutiawati, Endang, et al.
Publicado: (2021)

Dysgeusia in COVID-19: Possible Mechanisms and Implications
por: Lozada-Nur, Francina, et al.
Publicado: (2020)

Dysgeusia: A review in the context of COVID-19
por: Thomas, Davis C., et al.
Publicado: (2022)

Anosmia and ageusia
por: Tarakji, B., et al.
Publicado: (2020)

Dysosmia and dysgeusia in patients with COVID-19 in northern Taiwan
por: Sheng, Wang-Huei, et al.
Publicado: (2021)

Sodium valproate: cacosmia and dysgeusia as uncommon side effects
por: Montalbano, Clara, et al.
Publicado: (2023)

Anosmia in COVID-19 Patients: Can We Predict the Severity of Chest Manifestations?
por: Hendawy, Ehsan, et al.
Publicado: (2023)

Geographical Variations in Host Predisposition to COVID-19 Related Anosmia, Ageusia, and Neurological Syndromes
por: Kumar, A Aravin, et al.
Publicado: (2021)

Vestibular Schwannoma Presenting as Oral Dysgeusia: An Easily Missed Diagnosis
por: Brown, Emma, et al.
Publicado: (2016)

COVID-19-Associated Parosmia and Dysgeusia: A Case Series
por: Ivona, Javier A, et al.
Publicado: (2021)

Olfaction and anosmia in rhinosinusitis
por: Dalton, Pamela
Publicado: (2004)

The aftermath of COVID-19: between anosmia and ageusia()
por: Medina Gamero, Aldo, et al.
Publicado: (2022)

Can the coronavirus infection penetrates the brain resulting in sudden anosmia followed by severe neurological disorders?
por: Anwar, Mai M., et al.
Publicado: (2020)

Headache, anosmia, ageusia and other neurological symptoms in COVID-19: a cross-sectional study
por: Sampaio Rocha-Filho, Pedro Augusto, et al.
Publicado: (2022)

345. Dermatological Manifestations in Patients with COVID-19 Pneumonia in Veracruz, Mexico
por: Del Carpio-Orantes, Luis, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_st1dojmlukeor90lstv42dq47o